MAP2 and ischemia: In addition to the loss of NeuN immunoreactivity, we also found significant losses of MAP2 immunoreactivity in the pyramidal layers of CA1 and part of CA3, suggesting degeneration of neuronal dendrites induced by ischemia (Fig. 2E).